$MAC

Macerich Announces Commencement of Public Offering of Common Stock

Macerich (NYSE: MAC) said it has started an underwritten public offering of 14,000,000 shares of common stock, with Goldman Sachs & Co. LLC as lead bookrunner. The underwriters have a 30-day option to buy up to 2,100,000 additional shares. Macerich expects to enter forward sale agreements with financial institutions; it will not receive initial proceeds, with net proceeds expected upon future settlement to fund acquisitions and general corporate purposes.

Original reporting
Published Jun 15, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Macerich Announces Commencement of Public Offering of Common Stock — source image
Decision brief

The 30-second read

$MACBearishMed
01

Why it matters

The offering is designed to set the share price at offering pricing while delaying issuance/cash receipt until future settlement; net proceeds (if any) are intended for acquisitions and general corporate purposes.

02

Market read

Traders should focus on dilution expectations, offering pricing/terms (not provided here), and the timeline for settlement and capital deployment.

03

What to watch

Key sensitivities are the forward sale price terms, any hedging/net share settlement election conditions, and how quickly management deploys capital into accretive acquisitions.

Relevance 7/10Novelty 8/10Timing: offering commenced June 15, 2026; forward settlement dates extend to no later than June 16, 2027

Background

Macerich (a self-managed REIT) announced commencement of an underwritten public offering using forward sale agreements, with underwriters able to buy an additional tranche via a 30-day option.

Company-level read

Ticker impact

$MACBearishMedium confidence
Context

Macerich commenced an underwritten public offering of 14,000,000 shares via forward sale agreements, with an option for 2,100,000 more.

Expected impact

Choppy-to-negative bias around the offering execution and any subsequent pricing/settlement details; longer-dated impact depends on acquisition deployment.

Evidence & confidence

The company explicitly starts a sizable common-stock offering and notes it initially receives no proceeds, which typically weighs on REIT equity sentiment even if capital is intended for growth.

Market effects

Adds to the broader REIT financing/issuance narrative; may modestly influence sentiment toward retail REIT peers if capital markets are tight.

No direct regional read-through beyond general US retail real estate capital availability.

Primarily US capital markets/REIT-specific; limited global spillover.

Counterpoint

Forward sale structure delays cash receipt and can help manage timing; if acquisition pipeline is strong, the market may re-rate MAC after settlement/pricing clarity.

Key entities

  • Macerich

    Announced commencement of an underwritten public offering of common stock via forward sale agreements.

  • Goldman Sachs & Co. LLC

    Lead bookrunner/representative of underwriters for the offering.

Related articles

$MACMed

Macerich (MAC) Q2 2026 Earnings Call Transcript

Macerich (MAC) reported Q2 2026 results on an earnings call. Adjusted FFO was $0.35 per diluted share, with go-forward portfolio NOI up 3.8%. SNO pipeline was $124 million. Leased occupancy was 94% for the portfolio and 95.5% for the go-forward portfolio. Portfolio sales were $919 per sq ft, $954 for go-forward. The company said it has $372 million available for acquisitions.

$MACMedAI 8/10

Macerich Company: Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031

Macerich (NYSE: MAC) priced an upsized $675 million offering of 2.25% exchangeable senior notes due 2031, up from $600 million. The notes settle Aug. 11, 2026, pay 2.25% semiannually, mature Aug. 15, 2031, and are exchangeable into MAC shares at an initial rate of 35.4761 shares per $1,000 principal. Net proceeds are about $659.1 million.

$MACMed

The Macerich Company Q2 2026 Earnings Call Summary

Macerich reported progress on its Path Forward 3.0 plan, with leasing completion at 88% versus a midyear 85% target. Management reiterated 2026 go-forward portfolio NOI growth of at least 3%, accelerating to 3.5%+ in 2H, and expects >8% NOI growth in 2027-28 as a $140 million SNO pipeline contributes rent. Net debt/adj. EBITDA improved to 7.3x. The company plans $372 million of unsettled forward equity for acquisitions and noted a $76 million loan default at 29th Street.

$MACMed

Mall Giant Macerich Narrows Losses in Q2 Amid Stronger Leasing

Macerich (a mall REIT) reported Q2 leased occupancy of 94% (up from 92% a year earlier) after signing about 1.3 million sq ft of new and renewal leases. Lease revenue was $233.4M and total revenue $249.7M. Adjusted FFO was $100.4M. Net loss narrowed to $27.1M from nearly $41M, helped by asset sales. Go-forward NOI rose 3.8% and the company cited $1.2B liquidity.

$MACMed

MACERICH CO (MAC): Results of Operations and Financial Condition

MACERICH CO (MAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2-exhibit991.htm EX-99.1 2026 Q2- Exhibit 99.1 Exhibit 99.1 Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 2026 The Macerich Company Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 20

$MACMed

Macerich (NYSE:MAC) Stock Rating Upgraded by JPMorgan Chase & Co.

JPMorgan upgraded Macerich (NYSE:MAC) from “underweight” to “neutral” and set a $25.00 price target, implying 5.34% upside from the prior close, according to MarketBeat. Other firms cited include Deutsche Bank (to “buy,” $27 target) and Goldman Sachs (to “sell,” $19 target). Macerich reported $0.34 EPS and $241.54M revenue for Q ended May 6.